3-Nitropyridine | CAS:2530-26-9
3-Nitropyridine
- Name：3-Nitropyridine
- CAS：2530-26-9
- Synonyms：
- Molecular Formula：C5H4N2O2
- Molecular Weight：124.10
- EINESC：
Description
Properties
| Melting point | 35-40 ºC |
|---|
Safety
| Symbol(GHS) | F;Xn |
|---|---|
| Hazard Codes | R11;R20/21/22 |
| SDS/MSDS | S16;S26;S37/39 |
SDS
| Source | SDS/MSDS Samples |
|---|---|
| Alfa-Aesar | View & Download |
| Sigma-Aldrich | View & Download |
| TCI | View & Download |
Synthetic Route
| Name | CAS |
|---|
More
Articles
Peer-Reviewed Papers
Simultaneous liquid chromatographic assay of amantadine and its four related compounds in phosphate-buffered saline using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent derivatization reagent.Yasuhiko Higashi et al.Biomedical chromatography : BMC, 20(5), 423-428 (2005-09-15)
Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.Anna N Tevyashova et al.The Journal of antibiotics, 62(1), 37-41 (2009-01-10)
Inhibition of lymphocyte proliferation by amantadine and its isomer, 2-aminoadamantane; impact on Lyt-2+ T cells while sparing L3T4+ T cells.C Clark et al.Immunopharmacology, 21(1), 41-50 (1991-01-01)
Development and validation of an LC-MS/MS method for the quantitative analysis of the anti-influenza agent camphecene in rat plasma and its application to study the blood-to-plasma distribution of the agent.Alina A Okhina et al.Journal of pharmaceutical and biomedical analysis, 180, 113039-113039 (2019-12-23)
[DNA macroarray analysis of gene expression changes in rat brain after single administration of 2-aminoadamantane compound].Iu V Vakhitova et al.Molekuliarnaia biologiia, 39(2), 276-285 (2005-04-29)
[A quantitative pharmaco-electroencephalographic analysis of the action of bromantane].S V Krapivin et al.Biulleten' eksperimental'noi biologii i meditsiny, 116(11), 515-518 (1993-11-01)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
| Name | CAS |
|---|
Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!